Ennostar Inc. (TWSE: 3714) has announced the planned merger of its two core subsidiaries—EPISTAR and Lextar—into a single entity named Ennostar Corporation, in response to fast-evolving industry dynamics and intensifying market competition. The move aims to accelerate organizational integration and enhance overall operational efficiency. As part of this transition, EPISTAR will be officially renamed Ennostar Corporation on October 1, 2025. The full merger, including structural and organizational adjustments, is expected to be completed by January 1, 2026.